Renaissance Capital logo

TP News

US IPO Weekly Recap: August kicks off with flurry of biotech IPOs

BRVE

Six IPOs and five SPACs priced this week. Two IPOs and eight SPACs submitted filings. Cardiovascular disease biotech Braveheart Bio (BRVE) upsized and priced above the range, raising $383 million at a $1.6 billion market cap. Its lead candidate, BHB-1893, is ...read more

Latin American ticket platform Ticketplus prices US IPO at $8, the low end of the range

Ticketplus logo

Ticketplus, a Latin American live event ticket marketplace and event software provider, raised $15 million by offering 1.9 million shares at $8, the low end of the $8 to $10 range. The company had originally filed to raise $25 million by offering shares at $13...read more

Latin American ticket marketplace Ticketplus lowers deal size by 33% ahead of $17 million US IPO

Ticketplus logo

Ticketplus, a Latin American live event ticket marketplace and event software provider, lowered the proposed deal size for its upcoming IPO on Tuesday. The Santiago, Chile-based company now plans to raise $17 million by offering 1.9 million shares at a price...read more

US IPO Week Ahead: Specialized manufacturing company plans a $700 million IPO

DPC

Three IPOs are currently on the calendar for the week ahead, though smaller issuers may join throughout the week. Engine products manufacturer DPC Holdings (DPC) plans to raise $700 million at a $4.2 billion market cap. Doing business as Doncasters, the...read more